_:n15d920be6b7b4ba79c990ebd8f9c38c1xb1
<http://schema.org/item>
<https://invivoscribe.com/us-fda-approves-invivoscribe-leukostrat-cdx-flt3-mutation-assay-as-cdx-and-astellas-drug-xospata-gilteritinib-fumarate-for-treatment-of-aml-patients-in-the-us/>